(Q46198074)

20 December 2017

title

Iron-mediated bioactivation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in glial cultures (English)

1 reference

20 December 2017

1 reference

3

1 reference

20 December 2017

author name string

Di Monte DA

series ordinal

1

1 reference

20 December 2017

Schipper HM

series ordinal

2

1 reference

20 December 2017

Langston JW

series ordinal

4

1 reference

20 December 2017

publication date

1 October 1995

1 reference

20 December 2017

number of pages

4

1 reference

inferred from page(s)

published in

Glia

1 reference

20 December 2017

volume

15

1 reference

20 December 2017

page(s)

203-206

1 reference

20 December 2017

issue

2

1 reference

20 December 2017

Role of iron and iron chelation in dopaminergic-induced neurodegeneration: implication for Parkinson's disease

cites work

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.440150213

7 January 2021

A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.440150213

7 January 2021

Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.440150213

7 January 2021

Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.440150213

7 January 2021

A high dose of MPTP overcomes the protective effect of selegiline against dopaminergic neurotoxicity

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.440150213

7 January 2021

Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.440150213

7 January 2021

1-Methyl-4-phenylpyridinium ion (MPP+): Identification of a metabolite of MPTP, a toxin selective to the substantia nigra

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.440150213

7 January 2021

Pargyline Prevents MPTP-Induced Parkinsonism in Primates

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.440150213

7 January 2021

Intraneuronal generation of a pyridinium metabolite may cause drug-induced parkinsonism.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.440150213

7 January 2021

An introduction to the free radical hypothesis in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.440150213

7 January 2021

A catalyst function for MPTP in superoxide formation

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.440150213

7 January 2021

Astrocytes convert the parkinsonism inducing neurotoxin, MPTP, to its active metabolite, MPP+

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.440150213

7 January 2021

Oxidation of the neurotoxic amine 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) by monoamine oxidases A and B and suicide inactivation of the enzymes by MPTP

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.440150213

7 January 2021

Gomori-positive astrocytes: Biological properties and implications for neurologic and neuroendocrine disorders

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.440150213

7 January 2021

Studies on the mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine cytotoxicity in isolated hepatocytes

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.440150213

7 January 2021

Effects of metal chelating agents on the oxidation of lipids induced by copper and iron

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.440150213

7 January 2021

Identifiers

DOI

10.1002/GLIA.440150213

1 reference

20 December 2017

PubMed ID

8567072

1 reference

20 December 2017